Drugs / Kinezodianone R
Kinezodianone R
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06394973 | Aug → Nov 2024 | glaucoma, ocular hypertension | Laboratoires Thea | Completed | Missed primary |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Kinezodianone R | “T4090 Ophthalmic Solution (Preservative-free Kinezodianone R HCl 0.2% or 0.3%)” NCT06394973 ↗ |
| Known as | Kinezodianone R HCl | “T4090 Ophthalmic Solution (Preservative-free Kinezodianone R HCl 0.2% or 0.3%)” NCT06394973 ↗ |
| Known as | T4090 | “T4090 Ophthalmic Solution (Preservative-free Kinezodianone R HCl 0.2% or 0.3%)” NCT06394973 ↗ |
| Route | Other | “1 drop in the conjunctival cul-de-sac of each eye once daily” NCT06394973 ↗ |